echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Blood System > Application of Delarosx film-coated tablets in pediatric patients with transfusion-dependent thalassemia: a single-center experience

    Application of Delarosx film-coated tablets in pediatric patients with transfusion-dependent thalassemia: a single-center experience

    • Last Update: 2022-10-12
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Research Background:

    Thalassemia syndrome is a recessive, inherited hemoglobinopathy characterized


    Research Objectives:

    A new deferasirox film-coated tablet (DFX FCT) is designed to provide a more convenient mode of administration and better tolerability


    Research Methods:

    This study is a prospective observational study of the safety and efficacy of DFX FCT in pediatric patients


    Results of the study:

    A total of 25 pediatric patients were selected


    Conclusion of the study:

    Overall, the use of DFX FCT proved safe in older children, but younger patients experienced adverse events – particularly an increase in liver enzyme values that did not respond


     

    References:

    Adramerina A, Printza N, Hatzipantelis E, Symeonidis S, Tarazi L, Teli A, Economou M.


     

     

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.